- Is Advancing Innovation in Dermatology a tax-exempt 501(c)(3)?
- Yes. Advancing Innovation in Dermatology is recognised by the IRS as a 501(c)(3) organisation (EIN 45-3153544). The IRS recognised Advancing Innovation in Dermatology as tax-exempt in June 2012.
- What is Advancing Innovation in Dermatology's EIN?
- Advancing Innovation in Dermatology's Employer Identification Number (EIN) is 45-3153544. The EIN was assigned by the IRS in June 2012. Donors and grantmakers use the EIN to verify tax-exempt status with the IRS.
- What does Advancing Innovation in Dermatology do?
- Advancing Innovation in Dermatology, Inc. supports and promotes the exchange of ideas in the field of Dermatology so that novel and important products can be developed for the treatment and care of skin.
- Where is Advancing Innovation in Dermatology located?
- Advancing Innovation in Dermatology is located at Co William Ju 435 Bernardsville R, Mendham, NJ, 07945.
- When was Advancing Innovation in Dermatology founded or recognised by the IRS?
- Advancing Innovation in Dermatology was recognised by the IRS as a tax-exempt organisation in June 2012. The IRS ruling date is the earliest authoritative date available for most US nonprofits.
- What is Advancing Innovation in Dermatology's annual revenue?
- On its most recent Form 990 (fiscal year 2025), Advancing Innovation in Dermatology reported $567K in total revenue and $565K in total expenses.
- Has Advancing Innovation in Dermatology been auto-revoked by the IRS?
- No. Advancing Innovation in Dermatology (EIN 45-3153544) does not appear on the IRS Auto-Revocation List. Givalgo Discover cross-references the IRS Auto-Revocation List on every profile load; if status changes, this page reflects it.
- Is Advancing Innovation in Dermatology listed in IRS Publication 78?
- Yes. Advancing Innovation in Dermatology is listed in IRS Publication 78 as an organisation eligible to receive tax-deductible charitable contributions. Pub 78 status is the canonical IRS signal that donations to an org are deductible.